249 related articles for article (PubMed ID: 20143154)
21. Possible risk modifications in the association between MnSOD Ala-9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial.
Chen Y; Pei J
Breast Cancer Res Treat; 2011 Jan; 125(2):495-504. PubMed ID: 20567899
[TBL] [Abstract][Full Text] [Related]
22. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ
Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
[TBL] [Abstract][Full Text] [Related]
23. No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls.
Ma X; Chen C; Xiong H; Fan J; Li Y; Lin H; Xu R; Huang G; Xu B
Breast Cancer Res Treat; 2010 Jul; 122(2):509-14. PubMed ID: 20052533
[TBL] [Abstract][Full Text] [Related]
24. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
[TBL] [Abstract][Full Text] [Related]
25. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review.
Bag A; Bag N
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3298-305. PubMed ID: 19064542
[TBL] [Abstract][Full Text] [Related]
26. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.
Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166
[TBL] [Abstract][Full Text] [Related]
27. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
Yao L; Fang F; Wu Q; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
[TBL] [Abstract][Full Text] [Related]
28. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer.
Tamimi RM; Hankinson SE; Spiegelman D; Colditz GA; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):989-96. PubMed ID: 15184255
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Elhan AH; Karakaya AE
Cell Biochem Funct; 2005; 23(1):73-6. PubMed ID: 15386537
[TBL] [Abstract][Full Text] [Related]
30. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
31. NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.
Wang Z; Cui D; Lu W
Breast Cancer Res Treat; 2010 Sep; 123(2):557-61. PubMed ID: 20143155
[TBL] [Abstract][Full Text] [Related]
32. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
[TBL] [Abstract][Full Text] [Related]
33. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies.
Gu D; Wang M; Zhang Z; Chen J
Breast Cancer Res Treat; 2010 Jul; 122(2):527-31. PubMed ID: 20054639
[TBL] [Abstract][Full Text] [Related]
34. MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.
Mao C; Qiu LX; Zhan P; Xue K; Ding H; Du FB; Li J; Chen Q
J Cancer Res Clin Oncol; 2010 Jul; 136(7):975-9. PubMed ID: 20012093
[TBL] [Abstract][Full Text] [Related]
35. Extremely low-frequency electromagnetic fields exposure and female breast cancer risk: a meta-analysis based on 24,338 cases and 60,628 controls.
Chen C; Ma X; Zhong M; Yu Z
Breast Cancer Res Treat; 2010 Sep; 123(2):569-76. PubMed ID: 20145992
[TBL] [Abstract][Full Text] [Related]
36. [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):808-13. PubMed ID: 17299970
[TBL] [Abstract][Full Text] [Related]
37. Glutathione S-transferase T1 polymorphism is associated with breast cancer susceptibility.
Chen XX; Zhao RP; Qiu LX; Yuan H; Mao C; Hu XC; Guo XM
Cytokine; 2011 Nov; 56(2):477-80. PubMed ID: 21741269
[TBL] [Abstract][Full Text] [Related]
38. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
[TBL] [Abstract][Full Text] [Related]
39. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
[TBL] [Abstract][Full Text] [Related]
40. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects.
Yu KD; Chen AX; Qiu LX; Fan L; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 123(1):219-25. PubMed ID: 20127279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
